10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

AVE Insider Trading (Avecho Biotechnology)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Avecho Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at Avecho Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avecho Biotechnology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/1/2021 01:08 PM ET

This chart shows the closing price history over time for AVE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
5 Signs That Inflation Is About To Wreck America
A weak dollar. 2. Limited supply of critical resources. 3. Prices are skyrocketing. 4. Demand is rising. (Sending prices even higher) 5. Treasury yields tripled over the last year!
How To Protect Your Wealth From This Inflation

Avecho Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/31/2021Matthew McNamaraInsiderIssued3,993,644A$0.02A$75,879.24
See Full Table
Insider Buying at Avecho Biotechnology?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Avecho Biotechnology and related companies.

SEC Filings (Institutional Ownership Changes) for Avecho Biotechnology (ASX:AVE)

Avecho Biotechnology logo
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, animal health, and nutrition industries in Australia and internationally. The company operates through Production, Human Health, and Other segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 is based in Clayton, Australia.
Read More on Avecho Biotechnology

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Avecho Biotechnology?

Avecho Biotechnology's top insider investors include:
  1. Matthew McNamara (Insider)
Next Plant-Based Unicorn
The plant-based industry has been ignited. Pay close attention to this stock.
Learn more.